HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Gerry Taylor Selected Research

Speech Sound Disorder

11/2021Psychosocial Comorbidities in Adolescents With Histories of Childhood Apraxia of Speech.
7/2021Association between genes regulating neural pathways for quantitative traits of speech and language disorders.
11/2019Reading Outcomes for Individuals With Histories of Suspected Childhood Apraxia of Speech.
11/2019Differential Long-Term Outcomes for Individuals With Histories of Preschool Speech Sound Disorders.
7/2018Heritability and longitudinal outcomes of spelling skills in individuals with histories of early speech and language disorders.
5/2016Psychosocial co-morbidities in adolescents and adults with histories of communication disorders.
5/2015Adolescent outcomes of children with early speech sound disorders with and without language impairment.
10/2014Association between AVPR1A, DRD2, and ASPM and endophenotypes of communication disorders.
9/2012Speech-Sound Disorders and Attention-Deficit/Hyperactivity Disorder Symptoms.
12/2011Literacy outcomes of children with early childhood speech sound disorders: impact of endophenotypes.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Gerry Taylor Research Topics

Disease

21Traumatic Brain Injuries (Traumatic Brain Injury)
04/2022 - 09/2009
15Speech Sound Disorder
11/2021 - 11/2006
3Cognitive Dysfunction
10/2018 - 08/2005
2Apraxias (Dyspraxia)
11/2021 - 07/2018
2Obstructive Sleep Apnea
01/2021 - 06/2013
2Hearing Loss (Hearing Impairment)
01/2018 - 01/2015
2Encephalomalacia
10/2016 - 07/2013
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
05/2016 - 09/2012
2Dyslexia (Alexia)
05/2016 - 11/2006
2Communication Disorders (Communication Disorder)
10/2014 - 12/2006
2Birth Weight (Birth Weights)
12/2006 - 11/2004
2Genetic Predisposition to Disease (Genetic Predisposition)
12/2006 - 11/2006
1Post-Concussion Syndrome
01/2022
1Neurodevelopmental Disorders
07/2021
1Down Syndrome (Down's Syndrome)
01/2021
1Genetic Risk Score
01/2020
1Speech Disorders (Cluttering)
11/2019
1Cerebral Palsy (Spastic Diplegia)
01/2018
1Inflammation (Inflammations)
01/2018
1Attention Deficit and Disruptive Behavior Disorders (Disruptive Behavior Disorder)
02/2017
1Substance-Related Disorders (Drug Abuse)
02/2017
1Brain Diseases (Brain Disorder)
01/2017
1Wounds and Injuries (Trauma)
01/2017
1Brain Injuries (Brain Injury)
12/2014
1Microcephaly
10/2014
1Atrophy
07/2013
1Brain Concussion (Cerebral Concussion)
09/2009
1Necrotizing Enterocolitis
12/2006
1Language Disorders (Language Disorder)
12/2006
1Prader-Willi Syndrome (Syndrome, Prader-Willi)
11/2006
1Autistic Disorder (Autism)
11/2006
1Lung Diseases (Lung Disease)
11/2004

Drug/Important Bio-Agent (IBA)

15Silver Sulfadiazine (SSD)FDA LinkGeneric
11/2021 - 11/2006
3Brain-Derived Neurotrophic Factor (BDNF)IBA
04/2022 - 01/2020
2Pharmaceutical PreparationsIBA
01/2021 - 02/2017
2Dopamine (Intropin)FDA LinkGeneric
07/2020 - 01/2017
2Proteins (Proteins, Gene)FDA Link
10/2018 - 10/2014
2Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
11/2017 - 05/2016
2HemosiderinIBA
10/2016 - 07/2013
2Apolipoprotein E4IBA
01/2016 - 09/2009
2Apolipoproteins E (ApoE)IBA
01/2016 - 09/2009
1MicroRNAs (MicroRNA)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2021
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
07/2020
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2020
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2020
1Biological ProductsIBA
01/2019
1Phosphotransferases (Kinase)IBA
12/2018
1Nerve Growth Factors (Neurotrophins)IBA
10/2018
1Dihydrotachysterol (AT 10)IBA
10/2018
1cupric sulfide (CuS)IBA
01/2018
1Indicators and Reagents (Reagents)IBA
01/2018
1Surface-Active Agents (Surfactants)IBA
01/2018
1TOPSIBA
01/2017
1TeaIBA
01/2017
1PlasticsIBA
12/2014
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
10/2014
1Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
10/2014
1Oxyhemoglobins (Oxyhemoglobin)IBA
06/2013
1ApolipoproteinsIBA
09/2009
1SteroidsIBA
12/2006
1Oxygen (Dioxygen)IBA
11/2004

Therapy/Procedure

11Therapeutics
01/2022 - 12/2006
1Tonsillectomy
01/2021
1Length of Stay
10/2016
1Artificial Respiration (Mechanical Ventilation)
01/2015
1Critical Care (Surgical Intensive Care)
08/2005